Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 18, 2004, Pages 4647-4650

  Arora, Vishal ^a   Salunkhe, Manikrao M ^a   Sinha, Neelima ^b   Sinha, Rakesh K ^b   Jain, Sanjay ^b  

^a Institute of Science   (India)

^b New Chemical Entity Research   (India)

Author keywords

Antibacterial; Aryloxy thioaryloxy derivatives; Oxazolidinone; Resistant bacteria

Indexed keywords

ANTIINFECTIVE AGENT; LINEZOLID; METICILLIN; OXAZOLIDINONE DERIVATIVE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STRUCTURE-ACTIVITY RELATIONSHIP;

NEGIBACTERIA; POSIBACTERIA;

EID: 8644238120     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.06.096     Document Type: Article

References (10)

1. W.A. Gregory, D.R. Brittelli, C.-L.J. Wang, M.A. Wuonola, R.J. McRipley, D.C. Eustice, V.S. Eberly, P.T. Bartholomew, A.M. Slee, and M. Forbes J. Med. Chem. 32 1989 1673
2. D.C. Eustice, P.A. Feldman, I. Zajac, and A.M. Slee Antimicrob. Agents Chemother 32 1988 1218
3. A.M. Slee, M.A. Wuonola, R.J. McRipley, I. Zajac, M.J. Zawada, P.T. Bartholomew, W.A. Gregory, and M. Forbes Antimicrob. Agents Chemother. 31 1987 1791
4. W.A. Gregory, D.R. Brittelli, C.-L.J. Wang, H.S. Kezar, R.K. Carlson, C.-H. Park, P.F. Corless, S.J. Miller, P. Rajagopalan, M.A. Wuonola, R.J. McRipley, V.S. Eberly, A.M. Slee, and M. Forbes J. Med. Chem. 33 1990 2569
5. C.-H. Park, D.R. Brittelli, C.-L.J. Wang, F.D. Marsh, W.A. Gregory, M.A. Wuonola, R.J. McRipley, V.S. Eberly, A.M. Slee, and M. Forbes J. Med. Chem. 35 1992 1156
6. Scrip World Pharmaceutical News, October 13, 1987; 1250, p 25. Pharmaprojects, April 12, 1995, PJB Publications Ltd., Richmond, Surrey, U.K. Pharmcast-International, February 1995; 7-1-484, 487
7. Brickner, S. J.; Hutchinson, D. K.; Barbachyn, M. R.; Garmon, S. A.; Grega, K. C.; Hendges, S. K.; Manninen, P. R.; Toops, D. S.; Ulanowicz, D. A.; Kilburn, J. O.; Glickman, S.; Zurenko, G. E.; Ford, C. W. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 1995; F 208, p 149
8. S.J. Brickner, D.K. Hutchinson, M.R. Barbachyn, P.R. Manninen, D.A. Ulanowicz, S.A. Garmon, K.C. Grega, S.K. Hendges, D.S. Toops, C.W. Ford, and G.E. Zurenko J. Med. Chem. 39 1996 673
9. 3 otherwise mentioned.
10. National Committee for Clinical Laboratory Standards (NCCLS), 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS Document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, PA